Back to mobile site

More on PFE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-12.8% Growth)
- Ratings (4.2 Score)
- Holders
- Dividends (7% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/4/26)
- M&A (N/A)
- M&A (N/A)
- M&A (6/30/20 *Est)
- M&A (3/31/23 *Est)
- M&A (12/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PFE Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 2.09B
Short-term investments 12.28B
Accounts receivable, less allowance for doubtful accounts 9.84B
Short-term loans
Inventories 7.51B
Taxes and other current assets
Assets of discontinued operations and other assets held for sale
Total current assets 38.5B
Long-term investments and loans
Property, plant and equipment, less accumulated depreciation 13.28B
Goodwill 56.28B
Identifiable intangible assets, less accumulated amortization 54.24B
Taxes and other noncurrent assets
Total assets 178.43B
Short-term borrowings, including current portion of long-term debt 13.63B
Accounts payable 3.48B
Dividends payable
Income taxes payable 1.16B
Accrued compensation and related items 2.05B
Other current liabilities
Liabilities of discontinued operations
Total current liabilities 34.76B
Long-term debt 30.44B
Pension benefit obligations 5.31B
Postretirement benefit obligations 1.81B
Noncurrent deferred tax liabilities 31.69B
Other taxes payable
Other noncurrent liabilities 6.06B
Total liabilities 114.83B
Preferred stock 25M
Common stock 461M
Additional paid-in capital 82.53B
Employee benefit trusts
Treasury stock -84.35B
Retained earnings 72.85B
Accumulated other comprehensive loss -8.21B
Total Pfizer Inc. shareholders' equity 63.31B
Equity attributable to noncontrolling interests 294M
Total shareholders' equity 63.6B
Total liabilities and shareholders' equity 178.43B